tirzepatide breast cancer study Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes and weight loss (Mounjaro, Zepbound)—can also shrink tumors in obese mice. Presented at ENDO 2025, the University of Michigan showed Clinical Implications of Mounjaro (Tirzepatide)
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9




























